Exchange: NASDAQ·Updated 04:00 PM EDT
News
all
press releases
Short Interest in ImageneBio, Inc. (NASDAQ:IMA) Increases By 51.7%
ImageneBio, Inc. (NASDAQ:IMA - Get Free Report) was the recipient of a large growth in short interest in April. As of April 15th, there was short interest totaling 587,281 shares, a growth of 51.7...
MarketBeat
More News
IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally?
ImageneBio shares jumped to their highest levels in more than a month after the company announced a $30 million fundraising from institutional investors.
Stocktwits
ImageneBio $30 Million Private Placement Ignites Stock
ImageneBio shares rise after a $30 million private placement to advance IMG-007 development for atopic dermatitis and alopecia areata.read more...
Benzinga
ImageneBio (NASDAQ:IMA) Stock Price Down 8.5% - Here's Why
ImageneBio (NASDAQ:IMA) Shares Down 8.5% - Here's What Happened...
MarketBeat
Atlas Venture Life Science Advisors LLC Buys New Position in ImageneBio, Inc. $IMA
Atlas Venture Life Science Advisors LLC bought a new position in shares of ImageneBio, Inc. (NASDAQ:IMA - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat
Wall Street Zen Upgrades ImageneBio (NASDAQ:IMA) to "Hold"
Wall Street Zen upgraded ImageneBio from a "strong sell" rating to a "hold" rating in a report on Saturday...
MarketBeat
BML Capital Management LLC Makes New Investment in ImageneBio, Inc. $IMA
BML Capital Management LLC purchased a new position in ImageneBio, Inc. (NASDAQ:IMA - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat
ImageneBio (NASDAQ:IMA) Shares Up 2.4% - Still a Buy?
ImageneBio (NASDAQ:IMA) Stock Price Up 2.4% - Still a Buy...
MarketBeat
ImageneBio (NASDAQ:IMA) Trading Up 0.5% - Should You Buy?
ImageneBio (NASDAQ:IMA) Shares Up 0.5% - Here's Why...
MarketBeat
Insider Buying: ImageneBio (NASDAQ:IMA) Director Acquires 16,000 Shares of Stock
ImageneBio, Inc. (NASDAQ:IMA - Get Free Report) Director Joseph Slattery acquired 16,000 shares of the company's stock in a transaction on Wednesday, December 24th. The shares were bought at an...
MarketBeat

Advertisement|Remove ads.